We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA Replication Determines Cell Cycle Duration

By LabMedica International staff writers
Posted on 10 Jul 2018
An international team of cell and molecular biologists found that DNA damage and danger of cancer development were minimized by a molecular mechanism that delays cell division (mitosis) until two complete copies of the cell's genome are created.

To maintain genome stability, cells have to replicate their DNA before dividing. More...
Upon completion of bulk DNA synthesis, the mitotic kinases CDK1 and PLK1 become active and drive entry into mitosis.

Investigators at the Karolinska Institutet (Stockholm, Sweden) and the University of Sussex (United Kingdom) tested the hypothesis that DNA replication determined the timing of mitotic kinase activation. To do this, they generated a double-degron system to rapidly deplete the essential DNA replication-initiation factor CDC6 (Cell division control protein 6 homolog). A degron is a portion of a protein that is important in regulation of protein degradation rates. Known degrons include short amino acid sequences, structural motifs and exposed amino acids (often lysine or arginine) located anywhere in the protein. Some proteins contain multiple degrons.

The investigators reported in the June 28, 2018, online edition of the journal Molecular Cell that untransformed human cells shortened the cell cycle and prematurely entered mitosis in the absence of DNA replication. Using RNAi and inhibitors to independently target DNA replication licensing or firing, they found similar results in cancer cells. They also found that abrogating CHK1 activity in transformed cells, or CHK1 and p38 activity in untransformed cells enhanced CDK activation specifically upon G1/S transition, supporting the notion of a DNA replication checkpoint in human cells.

In the presence of DNA replication, inhibition of CHK1 and p38 led to premature activation of mitotic kinases, which induced severe replication stress. These results demonstrated that, rather than merely being a cell cycle output, DNA replication was an integral signaling component that restricted activation of mitotic kinases. DNA replication thus functioned as a brake that determined cell cycle duration.

"By creating cells that cannot copy their DNA and by following protein activities over time in single cells, we found that DNA replication blocks the enzymes that trigger cell division. Immediately after DNA replication is completed, the machinery that starts cell division is activated. This fundamental mechanism contributes to determining when human cells will divide," said senior author Dr. Arne Lindqvist, senior researcher in cell and molecular biology at Karolinska Institutet.

Related Links:
Karolinska Institutet
University of Sussex


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.